Funding for this research was provided by:
European Regional Development Fund (CZ.1.05/1.1.00/02.0123)
Ministerstvo Zdravotnictví Ceské Republiky (NT13434-4/2012)
National Program of Sustainability II (LQ1605)
7th Framework Program of the European Union (316345)
Received: 18 May 2020
Accepted: 6 July 2020
First Online: 15 July 2020
: The study protocol adhered to the Helsinki declaration and all participants signed the informed consent. The Kardiovize Brno 2030 study was approved by the ethics committee of St Anne’s University Hospital, Brno, Czech Republic (reference number 2 G/2012) [CitationRef removed].
: Not applicable.
: The authors declare that they have no competing interests.